Home/Filings/4/0001562180-21-001265
4//SEC Filing

Humphrey Jeffrey 4

Accession 0001562180-21-001265

CIK 0001434418other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 4:53 PM ET

Size

5.6 KB

Accession

0001562180-21-001265

Insider Transaction Report

Form 4
Period: 2021-02-16
Humphrey Jeffrey
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-02-16+35,05535,055 total
    Exercise: $35.50Exp: 2031-02-15Common Stock (35,055 underlying)
Footnotes (1)
  • [F1]This option was granted on February 16, 2021, and the shares underlying the option vest in equal quarterly installments through February 16, 2025, subject to continued service.

Issuer

CONSTELLATION PHARMACEUTICALS INC

CIK 0001434418

Entity typeother

Related Parties

1
  • filerCIK 0001816944

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 4:53 PM ET
Size
5.6 KB